Pro-Pointer, Inc. Corporate Update

July 30, 2010, 6:53 p.m. EDT
LAS VEGAS, NV, Jul 30, 2010 (MARKETWIRE via COMTEX) –Pro-Pointer, Inc. (PINKSHEETS: PPII), through its wholly ownedsubsidiary, Coenzyme-A Technologies, Inc., is pleased to announce itslatest innovative proprietary formula the “PURE COENZYME-A.” “Ourproduct duplicates the biological functions used by the human body inthe creation of cellular energy,” stated Nickolaos Skoaras, PhD.,President / CEO of Coenzyme-A Technologies, Inc. “Coenzyme-A is themost active metabolic enzyme in the human body and as the initiatorof the human body’s primary energy cycle; this is the purest form ofenergy there is,” Skouras added. Coenzyme-A is energy pure andsimple. Besides its indispensable energy work, Coenzyme-A initiatesthe synthesis of a wide variety of other essentials substances. Theseinclude acetylcholine (the key neurotransmitter in the brain), thesteroid hormones (produced in the adrenal glands) and the sexhormones. It supports immune function, including the repair of DNAand RNA, plus healing from physical injury. It facilitates themanufacture of important components of connective tissue necessary tojoint health, particularly chondroitin sulfate and hyaluronic acid.Lastly, Coenzyme-A retards the development of lactic acid build upduring aerobic exercise preventing sore and stiff muscles.
ABOUT COENZYME-A TECHNOLOGIES, INC. — Coenzyme-A Technologies, Inc.is an innovative company that has applied new technology to theformulation and manufacture of a series of proprietary products whichaddress nutritional deficiencies that result from the stress ofmodern day living, chemical imbalances within the body, and thedeleterious effects of aging. Coenzyme-A is the first nutraceouticalmanufacture and utilization of cellular Coenzyme-A (The MasterCoenzyme). Coenzyme-A contains a specific set of substrates that aredesigned to assist the body in converting fats, carbohydrates andproteins into energy at the cellular level. See Company website — www.coenzyme-a.com .
FORWARD-LOOKING STATEMENTSThe information contained in thisrelease, other than historical information, consists offorward-looking statements within the meaning of Section 27A of theSecurities Act and Section 21E of the Exchange Act. These statementsmay involve risks and uncertainties that could cause actual resultsto differ materially from those described in such statements. Suchforward-looking statements involve known and unknown risks anduncertainties, including all business uncertainties relating toproduct development, marketing, market acceptance, future capitalrequirements, competition in general and other factors that may causeactual results to be materially different from those described hereinas anticipated, believed, estimated or expected. The Company is underno obligation to (and expressly disclaims any such obligation to)update or alter its forward-looking statements whether as a result ofnew information, future events or otherwise.
INVESTOR RELATIONS at:InvestSource, Inc.6352 Santa Ynez DriveHuntington Beach, CA 92647Phone (714) 847-2460Fax (714) 847-4987
Copyright 2010 Marketwire, Inc., All rights reserved.

Source